Expression of ret proto-oncogene in human neuroblastomas.

The human protooncogene ret: a communicative cadherin?

A new polymorphism in the ret protooncogene (RET).

The c-MYC protooncogene expression in cholesteatoma.

Expression of members of the chromogranin family in primary neuroblastomas.

Expression of the multidrug resistance, MDR1, gene in neuroblastomas.

Neurokinin-immunoreactivity in human neuroblastomas. Evidence for selective expression of the preprotachykinin (PPT) II gene.

Differential expression of Raf-1 protooncogene in resting and activated human leukocyte populations.

Mechanisms of X-ray-mediated protooncogene c-jun expression in radiation-induced human sarcoma cell lines.

Protooncogene expression in subpopulations of cells from leukemia patients.

Early protooncogene expression during hemin-induced differentiation of human erythroleukemic cells.

Dumbbell neuroblastomas in children.

Ionizing radiation regulates expression of the c-jun protooncogene.

Protooncogene expression in rat liver by polychlorinated biphenyls (PCB).

HOXB5 binds to multi-species conserved sequence (MCS+9.7) of RET gene and regulates RET expression.

Peripheral neuroblastomas in two dogs.

H-ras protooncogene mutations in human thyroid neoplasms.

Neoplastic transformation and tumorigenesis by the human protooncogene MYC.

Fighting Neuroblastomas with NBAT1.

Berberine-induced morphologic differentiation and down-regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells.

Therapeutic targets for neuroblastomas.

Electroacupuncture accelerated the expression of c-fos protooncogene in serotonergic neurons of nucleus raphe dorsalis.

A TaqI RFLP in the human ret proto-oncogene.

Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene.

Dominant and recessive molecular changes in neuroblastomas.

Suggest Documents

The human protooncogene ret: a communicative cadherin?

A new polymorphism in the ret protooncogene (RET).

The c-MYC protooncogene expression in cholesteatoma.

Expression of members of the chromogranin family in primary neuroblastomas.

Expression of the multidrug resistance, MDR1, gene in neuroblastomas.

Neurokinin-immunoreactivity in human neuroblastomas. Evidence for selective expression of the preprotachykinin (PPT) II gene.

Differential expression of Raf-1 protooncogene in resting and activated human leukocyte populations.

Mechanisms of X-ray-mediated protooncogene c-jun expression in radiation-induced human sarcoma cell lines.

Protooncogene expression in subpopulations of cells from leukemia patients.

Early protooncogene expression during hemin-induced differentiation of human erythroleukemic cells.

Dumbbell neuroblastomas in children.

Ionizing radiation regulates expression of the c-jun protooncogene.

Protooncogene expression in rat liver by polychlorinated biphenyls (PCB).

HOXB5 binds to multi-species conserved sequence (MCS+9.7) of RET gene and regulates RET expression.

Peripheral neuroblastomas in two dogs.

H-ras protooncogene mutations in human thyroid neoplasms.

Neoplastic transformation and tumorigenesis by the human protooncogene MYC.

Fighting Neuroblastomas with NBAT1.

Berberine-induced morphologic differentiation and down-regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells.

Therapeutic targets for neuroblastomas.

Electroacupuncture accelerated the expression of c-fos protooncogene in serotonergic neurons of nucleus raphe dorsalis.

A TaqI RFLP in the human ret proto-oncogene.

Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene.

Dominant and recessive molecular changes in neuroblastomas.

Expression of ret proto-oncogene in human neuroblastomas.

Recommend Documents

Follow Us